HIV Infection and Opioid Treatment Enable the Engraftment of Kaposi Sarcoma‐Like Tumors Into Immunocompetent Mice
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Julian Naipauer und 10 weiteren Autor:innen. Beteiligte Einrichtung: CONICET-Universidad de Buenos Aires, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Sarcoma, Kaposi, Disease Models, Animal, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NCI NIH HHS, Miami Center for AIDS Research.
Abstract (Originalsprache)
The Kaposi Sarcoma herpesvirus (KSHV) causes Kaposi sarcoma (KS), primary effusion lymphoma, a lymphoproliferative disease (KSHV‐multicentric Castleman's disease), and a cytokine inflammatory syndrome (KICS). These diseases occur more frequently, though not exclusively, among people living with HIV or other types of immune dysregulation. While limited KS can regress with immune reconstitution, such as through antiretroviral therapy (ART) in people living with HIV, there are currently no curative treatments for advanced KS. Preventive or therapeutic vaccines targeting KSHV could have a significant clinical impact; however, the development and testing of such strategies have been limited by the lack of preclinical models that faithfully recapitulate KS, including the presence of infected spindle cells and a relevant immune microenvironment. HIV/AIDS is an important cofactor for KS, and globally, the majority of individuals with KS are HIV‐infected. Current evidence indicates that HIV‐1 may enable KS progression through immunosuppression and promote pathogenesis by inducing inflammatory cytokines and producing secreted regulatory proteins like Tat and Nef. The design and testing of new therapeutic approaches based on pathogenesis are hampered by the lack of models that replicate KSHV oncogenesis in the context of HIV/AIDS. In the present study, we demonstrate that KSHV‐infected cells can form tumors in an immunocompetent mouse model after in vivo passage in nude mice and EcoHIV infection and/or morphine treatment, both of which have immunomodulatory and pro‐inflammatory effects. These tumors exhibit gene expression profiles and immune microenvironments that closely resemble those observed in human KS lesions. This novel KSHV tumor model in immunocompetent mice provides a valuable platform to test immunotherapeutic strategies for KS, including immunomodulatory agents, targeted antibody therapies, checkpoint inhibitors, and vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- CONICET-Universidad de Buenos Aires, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), Buenos Aires, Argentina.
- Department of Microbiology and Immunology, Miami Center for AIDS Research, University of Miami, Miami, Florida, USA.
- Centro de Investigaciones Inmunológicas Básicas y Aplicadas, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina.
- Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
- Department of Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
- Department of Life Sciences, GITAM University, Visakhapatnam, Andhra Pradesh, India.
ORCID-Profile: Julian Naipauer
Förderung
- NIH HHS
- NCI NIH HHS
- Miami Center for AIDS Research
- Consejo Nacional de Investigaciones Científicas y Técnicas
- National Cancer Institute
Zitieren
APA
Naipauer, J., Lacunza, E., Ahuja, A., Rosario, S., Canete, C. A. A., Abba, M. C., Cesarman, E., Ramakrishnan, S., Mesri, E., Roy, S., & Sharma, U. (2026). HIV Infection and Opioid Treatment Enable the Engraftment of Kaposi Sarcoma‐Like Tumors Into Immunocompetent Mice. Journal of Medical Virology. https://doi.org/10.1002/jmv.71035
Vancouver
Naipauer J, Lacunza E, Ahuja A, Rosario S, Canete CAA, Abba MC, et al. HIV Infection and Opioid Treatment Enable the Engraftment of Kaposi Sarcoma‐Like Tumors Into Immunocompetent Mice. Journal of Medical Virology. 2026. doi:10.1002/jmv.71035
BibTeX
@article{Naipauer2026,
author = {Naipauer, Julian and Lacunza, Ezequiel and Ahuja, Anuj and Rosario, Santas and Canete, Carolina Alejandra Alvarez and Abba, Martin C and Cesarman, Ethel and Ramakrishnan, Sundaram and Mesri, Enrique and Roy, Sabita and Sharma, Umakant},
title = {HIV Infection and Opioid Treatment Enable the Engraftment of Kaposi Sarcoma‐Like Tumors Into Immunocompetent Mice},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71035}
}
EUVIMED